Six analysts surveyed by Zacks expected $87.2 million. Staar Surgical expects full-year revenue in the range of $340 million to $345 million. This story was generated by Automated Insights (http ...

John Schneider, chair of Protect Our Kids’ Future: Vote No on 2, noted in a statement that “those responsible for the state’s ...

(Instead of: APAC sales growth of 4% (prior outlook was 7%), including approximately 2% growth in China (prior outlook was 10%). Staar Surgical (STAA) delivered earnings and revenue surprises of ...

- U.S. Food and Drug Administration (FDA) provides a clear regulatory pathway to Accelerated Approval for isaralgagene civaparvovec using data from ongoing Phase 1/2 STAAR study, avoiding ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ETCompany ParticipantsBrian Moore - VP, IRTom Frinzi - ...

For now, the state Department of Elementary and Secondary Education has released limited guidance on the ballot measure, ...

Imagine a reality where each zodiac sign is the ruler of its own alternate universe—a place perfectly tailored to its unique ...

That's changing with the second generation model. The new Blink Mini 2 is still a compact, affordable camera, but it also ...

Sangamo engaged with the FDA on alternative pathways to potential approval following analysis of clinical data from the Phase 1/2 STAAR study showing encouraging safety and efficacy data ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...